Skip to main
  1. Stocks
  2. Neuphoria Therapeutics Inc
  3. P/E Ratio
NEUP

NEUP P/E Ratio

P/E Ratio as of Oct 26, 2026: -0.55

Average-0.5538
Median-0.5500
Minimum-0.5900
Maximum-0.5200
-0.55
0.04 (6.78%)past month
The P/E ratio for NEUP is -0.55 as of Oct 26, 2026. This represents a increase of 161.90% compared to its 12-month average P/E ratio of -0.21. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Neuphoria Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Neuphoria Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Neuphoria Therapeutics Inc to industry peers.

NEUP P/E Ratio Insights

See Neuphoria Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in NEUP

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NEUP P/E Ratio Historic Data

DateStock priceP/E ratio
Oct 1, 2026$3.51-0.57
Sep 1, 2026$3.79-0.16
Aug 3, 2026$3.93-0.16
Jul 1, 2026$3.55-0.15
Jun 1, 2026$5.30-0.22
May 1, 2026$5.22-0.22
Apr 1, 2026$4.12-0.17
Mar 2, 2026$4.26-0.18
Feb 2, 2026$4.04-0.17
Jan 2, 2026$3.82-0.16

NEUP End of Year P/E Ratio

DateP/E ratioChange
2026-0.55+243.75%
2025-0.16-99.98%
2024-659.62+550.32%
2023-101.43-74.01%
2022-390.21-50.62%
2021-790.14—

FAQs About Neuphoria Therapeutics Inc (NEUP) P/E ratio

The latest P/E ratio of NEUP is -0.55, as of Oct 26, 2026. This is calculated based on its current stock price and earnings per share (EPS).

Neuphoria Therapeutics Inc’s last 12-month average P/E ratio is -0.21, compared to its current P/E ratio of -0.55. This reflects a increase of 161.90%.

Neuphoria Therapeutics Inc’s current P/E ratio of -0.55 is higher than its last 12-month average P/E of -0.21. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Neuphoria Therapeutics Inc’s average P/E ratio over the last 3 years is -71.36. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Neuphoria Therapeutics Inc’s average P/E ratio over the last 5 years is -224.87. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Neuphoria Therapeutics Inc (NEUP)


NEUP P/E Ratio Insights

See Neuphoria Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in NEUP

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover NEUP stock data and trends